CYT — Cyteir Therapeutics Share News
0.000.00%
Last trade - 00:00- $111.95m
- -$17.29m
Brief: Cyteir Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results
Cyteir Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Cyteir Therapeutics Appoints Stephen Sands To Board Of Directors
Brief: Cyteir Therapeutics Announces First Patient Dosed In Phase 2 With Cyt-0851
U.S. RESEARCH ROUNDUP-Cerence, UTZ Brands, Zimmer Biomet Holdings
Brief: Cyteir Therapeutics Announces The Appointment Of John Thero To Board Of Directors
Brief: Cyteir Therapeutics Announces First Patient Dosed In Phase 1 Combination Trial With CYT-0851
Brief: Cyteir Therapeutics Appoints Jeffrey S. Humphrey To Board
Brief: Cyteir Therapeutics Reports Third Quarter 2021 Financial Results
Brief: Cyteir Therapeutics To Join Russell 2000 Index
Cyteir Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. RESEARCH ROUNDUP- Angel Oak Mortgage, Century Therapeutics, Zoetis
Brief: RA Capital Management Reports 9.4% Passive Stake In Cyteir Therapeutics Inc As Of June 22 - SEC Filing
NASDAQ RESUMED AT 09:46 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM
Brief: Cyteir Therapeutics Shares Open 8.3% Below IPO Price In Market Debut
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM